Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui Qin

Showing results (761-770 of 861) with videos related to

Pageof 87
Sort By:
European Urology|December 25, 2018
Guidelines for Reporting of Statistics for Clinical Research in UrologyMelissa Assel, Daniel Sjoberg, Andrew Elders, et al.
Investigational New Drugs|July 27, 2013
Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignanciesShaji K Kumar, James Jett, Randolph Marks, et al.
BMC Cardiovascular Disorders|February 13, 2025
Prognostic prediction of long-term survival in patients with type A aortic dissection undergoing surgical repair: development of a novel prognostic indexHao Cai, Yue Shao, Zheng-Hao Li, et al.
BJU International|December 12, 2018
Guidelines for reporting of statistics for clinical research in urologyMelissa Assel, Daniel Sjoberg, Andrew Elders, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identificationChu-Biao Xue, Xiaohua He, John Roderick, et al.
Investigational New Drugs|September 13, 2021
Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignanciesJoleen M Hubbard, Jun Yin, Erin L Schenk, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2007
Discovery of beta-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitorsJames J-W Duan, Lihua Chen, Zhonghui Lu, et al.
Menopause (New York, N.Y.)|November 26, 2014
North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashesHaeseong Park, Rui Qin, Thomas J Smith, et al.
Journal of Ethnopharmacology|May 6, 2023
Effect of Jiawei Tongqiao Huoxue decoction in basilar artery dolichoectasia mice through yes-associated protein/transcriptional co-activator with PDZ-binding motif pathwayFei Xiang Liu, Dao Pei Zhang, Yan Min Ma, et al.
Chinese Medical Journal|September 14, 2004
Crosstalk between ERK1/2 and STAT3 in the modulation of cardiomyocyte hypertrophy induced by cardiotrophin-1Yong-Jun Li, Wei Cui, Ze-Jun Tian, et al.
Pageof 87

Showing results (761-770 of 861) with videos related to

Sort By:
Pageof 87
European Urology|December 25, 2018
Guidelines for Reporting of Statistics for Clinical Research in UrologyMelissa Assel, Daniel Sjoberg, Andrew Elders, et al.
Investigational New Drugs|July 27, 2013
Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignanciesShaji K Kumar, James Jett, Randolph Marks, et al.
BMC Cardiovascular Disorders|February 13, 2025
Prognostic prediction of long-term survival in patients with type A aortic dissection undergoing surgical repair: development of a novel prognostic indexHao Cai, Yue Shao, Zheng-Hao Li, et al.
BJU International|December 12, 2018
Guidelines for reporting of statistics for clinical research in urologyMelissa Assel, Daniel Sjoberg, Andrew Elders, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identificationChu-Biao Xue, Xiaohua He, John Roderick, et al.
Investigational New Drugs|September 13, 2021
Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignanciesJoleen M Hubbard, Jun Yin, Erin L Schenk, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2007
Discovery of beta-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitorsJames J-W Duan, Lihua Chen, Zhonghui Lu, et al.
Menopause (New York, N.Y.)|November 26, 2014
North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashesHaeseong Park, Rui Qin, Thomas J Smith, et al.
Journal of Ethnopharmacology|May 6, 2023
Effect of Jiawei Tongqiao Huoxue decoction in basilar artery dolichoectasia mice through yes-associated protein/transcriptional co-activator with PDZ-binding motif pathwayFei Xiang Liu, Dao Pei Zhang, Yan Min Ma, et al.
Chinese Medical Journal|September 14, 2004
Crosstalk between ERK1/2 and STAT3 in the modulation of cardiomyocyte hypertrophy induced by cardiotrophin-1Yong-Jun Li, Wei Cui, Ze-Jun Tian, et al.
Pageof 87